The Efficacy and Safety of Keverprazan for Helicobacter Pylori Eradication
Status:
NOT_YET_RECRUITING
Trial end date:
2026-01-01
Target enrollment:
Participant gender:
Summary
The purpose of this study was to compare the efficacy of 14-day eradication of Helicobacter pylori with different doses of Keverprazan combined with Amoxicillin dual therapy and Keverprazan-based bismuth quadruple therapy and compare the adverse reactions, compliance, and factors affecting the efficacy of eradication schemes among different groups.
Phase:
EARLY_PHASE1
Details
Lead Sponsor:
Nanjing First Hospital, Nanjing Medical University